Henterone, Kaissey .

HRN: 01-14-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2025
AMPICILLIN 1GM (VIAL)
04/12/2025
04/18/2025
IV
2 Grams
Every 6 Hours
Premature Rupture Of Membranes
Waiting Final Action 
04/12/2025
CEFUROXIME 1.5GM (VIAL)
04/12/2025
04/18/2025
IV
1.5g
Q8
LTCS
Waiting Final Action 
04/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/12/2025
04/18/2025
IV
500mg
Q8
Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: